Product Wiki · Recalls · EU Safety Gate (RAPEX)

Eyeliner — recall SR/01724/26

EU Safety Gate (RAPEX) · Denmark · 2026-06-12 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01724/26
Date of alert
2026-06-12
Country / jurisdiction
Denmark
Risk level
Serious risk
Risk type
Environment
Brand
Barry M
Product category
Cosmetics
Product type
Eyeliner
🔴 Serious hazard — Reported risk: Produktet indeholder perfluornonyldimethicon, som er en forbindelse relateret til perfluoroktansyre (PFOA). PFOA udgør en risiko for menneskers sundhed og miljøet. Produktet overholder ikke forordningen om persistente organiske forurenende stoffer (POP) og REACH-forordningen.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Stop of sales
Date of entry into force
27/02/2025
Type of economic operator taking notified measure
Distributor
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Risk Description (original English): The product contains perfluorononyl dimethicone, which is a perfluorooctanoic acid (PFOA) related compound. PFOAs pose a risk to human health and the environment.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10099259

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.